Form 4: Telesis Bio Inc. Director Christine Tsingos Reports Changes in Beneficial Ownership

Director Christine Tsingos reports acquisition of restricted stock units and stock options in Telesis Bio Inc.

Summary

• On July 6, 2023, Christine Tsingos, a director of Telesis Bio Inc., acquired 46,752 shares of common stock through restricted stock units (RSUs) at a price of $0.
• On the same date, she was also granted stock options to purchase 70,129 shares of common stock at an exercise price of $1.54, which will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting of the Issuer's stockholders following the date of grant.
• On May 1, 2024, Tsingos acquired 37,109 shares of common stock through RSUs at a price of $0.
• On the same date, she was also granted stock options to purchase 30,362 shares of common stock at an exercise price of $0.3557, which will vest on the earlier of the one-year anniversary of the grant date or the date of the annual meeting of the Issuer's stockholders following the date of grant.
• 16,868 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
• Following these transactions, Tsingos directly owns 104,491 shares of common stock, and stock options for 100,491 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating changes in ownership, which can be seen as a positive sign of insider confidence, but doesn't provide enough information to be strongly positive.

Positives

• The acquisition of shares and stock options by a director signals confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice for company insiders to report changes in their ownership of company securities, providing transparency to the market.

Stakeholder Impact

• The increased ownership stake of a director could be viewed positively by shareholders.

Key Dates

Keywords

Telesis Bio Inc., Christine Tsingos, Form 4, Beneficial Ownership, RSUs, Stock Options, Director